Recipharm says no decision yet on rumoured IPO
Recipharm says it has not decided whether to go public and list on the Swedish stock market after reports suggested it is preparing to join the exchange.
Archives for February 6, 2014
Targeted drug delivery driving partnerships, says expert
An increased trend in dealmaking for targeted drug delivery last year will continue to drive partnerships in 2014, according to a pharmaceutical partnering expert.
US FDA Commissioner to travel to India in February
US Food and Drug Administration Commissioner Margaret Hamburg will travel to India from February 10-18 to strengthen the agency’s cooperation with Indian regulators at a time when India needs some direction.
FDA: shortage mitigation measures working thanks to drugmakers
US drug regulators have claimed recent law changes that enhance communication with pharmaceutical manufacturers helped prevent 140 potential drug shortages in 2013.
inVentiv partners with NeuroVive to bring cardio, neurological drugs to market
inVentiv Health has extended its partnership with NeuroVive Pharmaceutical AB to bring their drugs to treat acute cardiovascular and neurological conditions to market.
Jubilant denies speculation it will sell its fine chemical business
Jubilant Life Sciences has dismissed claims it is looking to sell off its fine chemicals business.
Johnson Matthey seeks Schedule II license renewal
Fine chemicals firm Johnson Matthey has asked the US to renew its license to make controlled substance drug APIs at its plant in Devens, Massachusetts